Lisbeth Keplinger
Foot & Ankle Surgery · Fullerton, CANPI 1053571828
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $36,400 of the $53,699 with a category attached, or 67.8%. Paragon 28, Inc. accounts for 90.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $38,987 and has fallen 90.3% since, to $3,772 in 2025. Among foot & ankle surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $553.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$48K
- Arthrex$4K
- Stryker$909
- Smith+Nephew$194
- Vital Orthopedics LLC$136
- Nevro Corp.$135
- plus $490 from 8 others
What the payments were for
- Consulting fees$36,40068%
- Travel & lodging$9,12017%
- Food & beverage$5,0669%
- Education$3,1146%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 49 | $48,332 |
| Arthrex | 7 | $3,502 |
| Stryker | 24 | $909 |
| Smith+Nephew | 4 | $194 |
| Vital Orthopedics LLC | 1 | $136 |
| Nevro Corp. | 1 | $135 |
| Amgen | 1 | $112 |
| Pfizer | 1 | $109 |
| Fusion Orthopedics USA, LLC | 2 | $88 |
| Scilex Pharmaceuticals Inc. | 1 | $65 |
| Integra Lifesciences Corporation | 3 | $51 |
| Johnson & Johnson | 1 | $32 |
| Bioventus LLC | 1 | $16 |
| Empire Medical, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$44,085
- Product Portfolio$1,287
- Bun-Yo-Matic$732
- PARATROOPER$647
- Additive Orthopedics$422
- APEX 3D$366
- Precision MIS Bunion$273
- EASYFUSE$166
- PROstep$153
- Grappler$143
- AUGMENT INJECTABLE$140
- Omnia$135
- Grafix PRIME$125
- Grafix CORE$125
- Grafix XC$125
- Grafix PL PRIME$125
- Stravix$125
- CITREFIX$125
- KRYSTEXXA$112
- EUCRISA$109
How this compares
$53,699 in reported general payments places this provider in the 95th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 15 | $229 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $132 |
| Doxycycline Hyclate | 23 | $114 |
| Oxycodone Hcl | 15 | $87 |
| Celecoxib | 12 | $87 |
| Cephalexin | 13 | $70 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Fullerton
- Eric NaaszFullerton$171K
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
- Eric TanLos Angeles$447K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.